Drug details

Sernivo (betamethasone dipropionate spray, 0.05%)

type of Corticosteroids, Topical

Sernivo (betamethasone dipropionate) Spray, 0.05% for topical use is a corticosteroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older.

This drug may have the following side effects:

• itching,
• burning,
• stinging,
• thinning skin
• pain, and

The following drugs are related to Sernivo, either as a replacement or used together:

• Humira (adalimumab injection solution for subcutaneous administration)
• Luxiq (betamethasone valerate foam)
• Tovet (clobetasol propionate foam)
• Cosentyx (secukinumab injection)
• Sandimmune (cyclosporine)
• Emerphed (ephedrine sulfate injection)
• Enbrel (etanercept)
• Remicade (infliximab)
• Trexall (methotrexate)
• Xatmep (methotrexate oral solution)
• Oxsoralen-Ultra (methoxsalen capsules)
• Oxsoralen (methoxsalen lotion)
• Stelara Injection (ustekinumab)